Hexarelin, a synthetic growth hormone releasing peptide, stimulates prolactin secretion in acromegalic but not in hyperprolactinaemic patients

Clinical Endocrinology

Volumn 44, Issue 1, 1996, Pages 67-71

  Ciccarelli, E ^a   Grottoli, S ^a   Razzore, P ^a   Gianotti, L ^a   Arvat, E ^a   Deghenghi, R ^b   Camanni, G ^a   Ghigo, E ^a,c  

^a UNIVERSITY OF TURIN   (Italy)

^b Ardana   (France)

^c MOLINETTE HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HEXARELIN; PROLACTIN; SOMATOMEDIN C;

ACROMEGALY; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUSHING; HUMAN; HYPERPROLACTINEMIA; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; SIDE EFFECT; SLEEP DISORDER;

EID: 0030028289     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1996.626446.x     Document Type: Article

References (24)

1. 2), GH-releasing hormone, and thyrotropin-releasing hormone in acromegaly. Journal of Clinical Endocrinology Metabolism, 77, 842-845.
2. Badger, T.M., Millard, W.Y., McCormick, G.F., Bowers, C.Y. & Martin, J.B. (1984) The effects of growth hormone (GH) releasing peptides on GH secretion in perfused pituitary cells of adult male rats. Endocrinology, 115, 1432-1438.
3. 2 stimulate GH release through different receptors sites. Journal of Endocrinology, 129, 11-19.
4. Bowers, C.Y. (1993) GH releasing peptides. Structure and kinetics. Journal of Pediatric Endocrinology, 6, 21-31.
5. Bowers, C.Y., Momay, F.A., Reynolds, G.A. & Hong, A. (1984) On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology, 114, 1537-1545.
6. Bowers, C.Y., Reynolds, G.A., Durham, D., Barrera, C.M., Pezzoli, S.S. & Thorner, M.O. (1990) Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. Journal of Clinical Endocrinology and Metabolism, 70, 975-982.
7. Bowers, C.Y., Sartor, A.O., Reynolds, G.A. & Badger, T.M. (1991) On the action of the growth hormone-releasing hexapeptide, GHRP. Endocrinology, 128, 2027-2035.
8. Camanni, F., Massara, F., Santià, M., Molinatti G.M. & Muller, E.E. (1982) Impaired prolactin responsiveness to dopamine antagonists in acromegaly. Metabolism, 31, 1090-1095.
9. Camanni, F., Ciccarelli, E., Ghigo, E. & Muller, E.E. (1989) Hyperprolactinemia: neuroendocrine and diagnostic aspects. Journal of Endocrinological Investigation, 12, 653-660.
10. 2 on growth hormone (GH)-releasing factor-stimulated GH release and intracellular adenosine 3′-5′-monophosphate accumulation in rat primary pituitary cell culture. Endocrinology, 124, 2791-2798.
11. Clemmons, D.R., Underwood, L.E., Ridgway, E.C., Kliman, B. & Van Wyk, J.J. (1981) Hyperprolactinemia is associated with increased immunoreactive somatomedin C in hypopituitarism. Journal of Clinical Endocrinology and Metabolism, 52, 731-735.
12. Codd, E.E., Shu, A.Y.L. & Walker, R.F. (1989) Binding of a growth hormone releasing hexapeptide to specific hypothalamic and pituitary binding sites. Neuropharmacology, 28, 1139-1144.
13. Deghenghi, R., Cananzi, M., Battisti, C., Locatelli, V. & Muller, E.E. (1992) Hexarelin (EP23905) a superactive growth hormone releasing peptide. Journal of Endocrinological Investigation, 15 (Suppl. 4), 45.
14. Ghigo, E., Arvat, E., Gianotti, L., Imbimbo, B.P., Lenaerts, V., Deghenghi, R. & Camanni, F. (1994) Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in man. Journal of Clinical Endocrinology and Metabolism, 78, 693-698.
15. Goth, M.i., Lyons, C.E., Canny, B.J. & Thorner, M.O. (1992) Pituitary adenylate cyclase activating polipeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone GH release thorugh distinct pituitary receptors. Endocrinology, 130, 939-944.
16. Hanew, K., Utsumi, A., Sugawara, A., Shimizu, Y. & Abe, K. (1994) Enhanced GH responses to combined administration of GHRP and GHRH in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 78, 509-512.
17. Ilson, B.E., Jorkasky, D.K., Curnow, R.T. & Stote, R.M. (1989) Effect of a new synthetic hexapeptide to selectively stimulate growth hormone release in healthy human subjects. Journal of Clinical Endocrinology and Metabolism, 69, 212-214.
18. Kelly, P.A., Djiane, J., Postel-Vinay, M.C. & Edery, M.C. (1991) The prolactin growth hormone receptor family. Endocrine Review, 12, 235-251.
19. Momay, F.A., Bowers, C.Y., Reynolds, G.A. & Newlander, K. (1984) Conformational energy studies and in vitro activity data on active GH releasing peptides. Endocrinology, 114, 1531-1536.
20. Muller, E.E. & Nisticò, G. (1989) Brain Messengers and the Pituitary, 432-446; 564-574. Academic Press, San Diego.
21. Popovic, V., Damjanovic, S., Micic, D., Petakov, M., Dieguez, C. & Casanueva, F.F. (1994) Growth hormone (GH) secretion in active acromegaly after the combined administration of GH-releasing hormone and GH-releasing peptide-6. Journal of Clinical Endocrinology and Metabolism, 79, 456-460.
22. Renner, U., Brockmeier, S., Strasburger, C.J., Lange, M., Schopohl, J., Muller, O.A., v. Werder, K. & Stalla, G.K. (1994) Growth hormone (GH)-releasing peptide stimulation of GH release from human somatotroph adenoma cells: interaction with GH-releasing hormone, thyrotropin-releasing hormone, and ocreotide. Journal of Clinical Endocrinology and Metabolism, 78, 1090-1096.
23. 2 in rat primary pituitary cell monolayer culture. Endocrinology, 116, 952-957.
24. Scanlon, M.F., Rodriguez-Arnao, M.D., McGregor, A.M., Weightmann, D.R., Lewis, M., Cook, D.B., Gomez-Pan, A. & Hall, R. (1981) Altered dopaminergic regulation of thyrotropin release in patients with prolactinomas: comparison with other tests of hypothalamic-pituitary function. Clinical Endocrinology, 14, 133-138.